We are Antioxidant 1024 CAS:32687-78-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
SPECIFICATIONS AND PHYSICAL CHARACTERISTICS
TEST | UNIT | SPECIFICATION |
APPEARANCE | WHITE POWDER | |
MELTING POINT | ℃ | 221.00-229.00 |
VOLATILES | % | 0.50MAX |
ASH | % | 0.10MAX |
TRANSMITTANCE | ||
425nm | % | 96.00MIN |
500nm | % | 97.00MIN |
ASSAY | % | 98.00MIN |
PRODUCT FEATURES AND APPLICATIONS
* Metal deactivator and antioxidant for wire and cable, adhesive (both hot melt and solution), and powder coatings applications
* Extraction resistant
* Effective in PE, PP, Cross Linked PE, EPDM, Elastomers, Nylon, PU, Polyacetal,and Styrenic copolymers
* Can be used as the primary antioxidant or can be used in combination with hindered phenolic antioxidants (particularly AN 1010) to achieve synergistic performance
– Standard blends of AN 1024 and AN 1010 are available.
PACKAGE
25Kg Carton,50KG Drum
HANDLING AND STORAGE
Keep container tightly closed and dry and storage in cool place
Related News: The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.[4- (3-cloro-4-fluoroanilino) -7-metoxiquinazolin-6-il] acetato, clorhidrato CAS:184475-70-5 The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.823-54-1 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.1-benzyl-6-bromo-3,4-dihydro-1H-quinoline-2,2-dicarboxylic acid diethyl ester “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.
Product Name | |
---|---|
6-Cyano-2-[1-[4-ethyl-3-[4-(4-morpholinyl)-1-piperidinyl]phenyl]-1-methylethyl]-1H-indole-3-carboxylic acid | View Details |
3-HYDROXYBUTYRIC ACID (Sodium salt) Cas:300-85-6 /CAS 150-83-4 | View Details |
DecaMethoxine Cas:38146-42-8 | View Details |